1. | ![]() |
Introduction for drug development and drug market | 1.1 What is a drug? 1.2 Process of drug development | ![]() |
2. | ![]() |
Drug-recepter interactions | 1.1 Absorption, Distribution, Metabolism, and Elimination | ![]() |
![]() |
Drug-recepter interactions | 1.2 Routes of drug administration | ![]() |
|
![]() |
Drug-recepter interactions | 1.3 Drug-Receptor interactions | ![]() |
|
3. | ![]() |
Nervous system | Drugs affecting the autonomic nervous system | ![]() |
![]() |
Nervous system | Actions of cholinergic agonists | ![]() |
|
![]() |
Nervous system | Adrenergic agonists, Neurotransmission at adrenergic neurons | ![]() |
|
4. | ![]() |
Actions of drugs | Drugs affecting the central Nervous system | ![]() |
![]() |
Actions of drugs | Drugs for Neurodegenerative diseases | ![]() |
|
5. | ![]() |
Neurodegenerative diseases | Neurodegenerative diseases, Anxiolytic and Hypnotic drugs | ![]() |
![]() |
Neurodegenerative diseases | The antipsychotic drugs, Schizophrenia | ![]() |
|
6. | ![]() |
Experimental tools | Cell culture, Animal experiments, Clinical trials | ![]() |
![]() |
Experimental tools | In vitro, In vivo | ![]() |
|
7. | ![]() |
Antidepressants | Depression, Mania | ![]() |
![]() |
Antidepressants | Anticoagulants and Antiplatelet Agents | ![]() |
|
![]() |
Antidepressants | Platelet aggregation inhibitors, Anticoagulants, Thrombolytic drugs, Drugs used to treat bleeding | ![]() |
|
8. | ![]() |
Anticoagulants | Drugs for antiplatelet agents | ![]() |
9. | ![]() |
Drugs for diabetes | Diabetes | ![]() |
![]() |
Drugs for diabetes | Diabetes Mellitus | ![]() |
|
10. | ![]() |
Dermatologic disorders | cosmetic and drugs for dermatologic disorders: The skin | ![]() |